IP Verse

Manufacture Of Degarelix

Patent No. EP2854831 (titled "Manufacture Of Degarelix") was filed by Ferring on May 31, 2013. The application was issued on Jul 10, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (4)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
ACCORD HEALTHCAREApr 10, 2025BRAND MURRAY FULLER
GRAF VON STOSCH PATENTANWALTSGESELLSCHAFTApr 10, 2025LEPTHIEN
ZIMMERMANN & PARTNER PATENTANWALTE MBBApr 10, 2025ZIMMERMANN & PARTNER PATENTANWALTE MBB
KRAUS & LEDERER PARTGMBBMar 24, 2025KRAUS & LEDERER PARTGMBB

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2854831

FERRING
Application Number
EP13726219A
Filing Date
May 31, 2013
Status
Granted And Under Opposition
Jun 7, 2024
Publication Date
Jul 10, 2024
External Links
Slate, Register , Google Patents